• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

激酶缺陷型Hck可抑制Bcr-Abl介导的髓系白血病细胞向细胞因子非依赖状态的转化。

Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.

作者信息

Lionberger J M, Wilson M B, Smithgall T E

机构信息

Department of Molecular Genetics, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261, USA.

出版信息

J Biol Chem. 2000 Jun 16;275(24):18581-5. doi: 10.1074/jbc.C000126200.

DOI:10.1074/jbc.C000126200
PMID:10849448
Abstract

Bcr-Abl is the constitutively active protein-tyrosine kinase expressed as a result of the Philadelphia translocation in chronic myelogenous leukemia. Bcr-Abl is coupled to many of the same signaling pathways normally regulated by hematopoietic cytokines. Recent work shows that Hck, a member of the Src tyrosine kinase family with myeloid-restricted expression, associates with and is activated by Bcr-Abl. Here we investigated the mechanism of Hck interaction with Bcr-Abl and the requirement for Hck activation in Bcr-Abl transformation signaling. Binding studies demonstrated that the Hck SH3 and SH2 domains are sufficient for interaction with Bcr-Abl in vitro. Hck binding localizes to the Abl SH2, SH3, and kinase domains as well as the distal portion of the C-terminal tail. To address the requirement for endogenous Src family kinase activation in Bcr-Abl signaling, a kinase-defective mutant of Hck was stably expressed in the cytokine-dependent myeloid leukemia cell line DAGM. Kinase-defective Hck dramatically suppressed Bcr-Abl-induced outgrowth of these cells in the absence of cytokine compared with a control cell line expressing beta-galactosidase. In contrast, kinase-defective Hck did not affect cell proliferation in response to interleukin-3, suggesting that the effect is specific for Bcr-Abl. These data show that Hck interacts with Bcr-Abl through a complex mechanism involving kinase-dependent and -independent components and that interaction with Hck or other Src family members is essential for transformation signaling by Bcr-Abl.

摘要

Bcr-Abl是一种组成型活性蛋白酪氨酸激酶,由慢性粒细胞白血病中的费城染色体易位产生。Bcr-Abl与许多通常由造血细胞因子调节的相同信号通路相关联。最近的研究表明,Hck是Src酪氨酸激酶家族的成员,具有髓系限制性表达,与Bcr-Abl相关联并被其激活。在这里,我们研究了Hck与Bcr-Abl相互作用的机制以及Bcr-Abl转化信号中Hck激活的必要性。结合研究表明,Hck的SH3和SH2结构域足以在体外与Bcr-Abl相互作用。Hck的结合定位于Abl的SH2、SH3和激酶结构域以及C末端尾巴的远端部分。为了研究内源性Src家族激酶激活在Bcr-Abl信号传导中的必要性,在细胞因子依赖性髓系白血病细胞系DAGM中稳定表达了Hck的激酶缺陷突变体。与表达β-半乳糖苷酶的对照细胞系相比,激酶缺陷的Hck在没有细胞因子的情况下显著抑制了Bcr-Abl诱导的这些细胞的生长。相反,激酶缺陷的Hck不影响细胞对白介素-3的增殖反应,表明这种作用对Bcr-Abl具有特异性。这些数据表明,Hck通过一种涉及激酶依赖性和非依赖性成分的复杂机制与Bcr-Abl相互作用,并且与Hck或其他Src家族成员的相互作用对于Bcr-Abl的转化信号传导至关重要。

相似文献

1
Transformation of myeloid leukemia cells to cytokine independence by Bcr-Abl is suppressed by kinase-defective Hck.激酶缺陷型Hck可抑制Bcr-Abl介导的髓系白血病细胞向细胞因子非依赖状态的转化。
J Biol Chem. 2000 Jun 16;275(24):18581-5. doi: 10.1074/jbc.C000126200.
2
The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells.Src家族激酶Hck在髓系白血病细胞中将BCR/ABL与STAT5激活偶联起来。
EMBO J. 2002 Nov 1;21(21):5766-74. doi: 10.1093/emboj/cdf562.
3
The c-Fes protein-tyrosine kinase suppresses cytokine-independent outgrowth of myeloid leukemia cells induced by Bcr-Abl.c-Fes蛋白酪氨酸激酶可抑制由Bcr-Abl诱导的髓系白血病细胞不依赖细胞因子的生长。
Cancer Res. 2000 Feb 15;60(4):1097-103.
4
The interaction of the Bcr-Abl tyrosine kinase with the Src kinase Hck is mediated by multiple binding domains.Bcr-Abl酪氨酸激酶与Src激酶Hck的相互作用由多个结合域介导。
Leukemia. 2003 Feb;17(2):283-9. doi: 10.1038/sj.leu.2402778.
5
Selective pyrrolo-pyrimidine inhibitors reveal a necessary role for Src family kinases in Bcr-Abl signal transduction and oncogenesis.选择性吡咯并嘧啶抑制剂揭示了Src家族激酶在Bcr-Abl信号转导和肿瘤发生中的必要作用。
Oncogene. 2002 Nov 21;21(53):8075-88. doi: 10.1038/sj.onc.1206008.
6
Src family kinases phosphorylate the Bcr-Abl SH3-SH2 region and modulate Bcr-Abl transforming activity.Src家族激酶使Bcr-Abl的SH3-SH2区域磷酸化,并调节Bcr-Abl的转化活性。
J Biol Chem. 2006 Oct 13;281(41):30907-16. doi: 10.1074/jbc.M605902200. Epub 2006 Aug 15.
7
The Src family kinase Hck interacts with Bcr-Abl by a kinase-independent mechanism and phosphorylates the Grb2-binding site of Bcr.Src家族激酶Hck通过一种不依赖激酶的机制与Bcr-Abl相互作用,并使Bcr的Grb2结合位点磷酸化。
J Biol Chem. 1997 Dec 26;272(52):33260-70. doi: 10.1074/jbc.272.52.33260.
8
An inhibitor-resistant mutant of Hck protects CML cells against the antiproliferative and apoptotic effects of the broad-spectrum Src family kinase inhibitor A-419259.Hck的一种抑制剂抗性突变体可保护慢性粒细胞白血病细胞免受广谱Src家族激酶抑制剂A-419259的抗增殖和凋亡作用。
Oncogene. 2008 Nov 27;27(56):7055-69. doi: 10.1038/onc.2008.330. Epub 2008 Sep 15.
9
Activation of STAT3 by the Src family kinase Hck requires a functional SH3 domain.Src家族激酶Hck对STAT3的激活需要一个功能性的SH3结构域。
J Biol Chem. 2002 Nov 22;277(47):45680-7. doi: 10.1074/jbc.M204255200. Epub 2002 Sep 19.
10
Src family kinases mediate cytoplasmic retention of activated STAT5 in BCR-ABL-positive cells.Src 家族激酶介导 BCR-ABL 阳性细胞中激活的 STAT5 的细胞质滞留。
Oncogene. 2013 Aug 1;32(31):3587-97. doi: 10.1038/onc.2012.369. Epub 2012 Aug 27.

引用本文的文献

1
Discovery of Non-peptide Small Molecule Allosteric Modulators of the Src-family Kinase, Hck.Src家族激酶Hck的非肽小分子变构调节剂的发现
Front Chem. 2019 Nov 28;7:822. doi: 10.3389/fchem.2019.00822. eCollection 2019.
2
Bosutinib as a fourth-line therapy for a patient with T315I-positive lymphoid blastic phase chronic myeloid leukemia: A case report.博舒替尼作为T315I阳性淋巴母细胞期慢性髓性白血病患者的四线治疗:一例报告
Oncol Lett. 2017 Jun;13(6):4285-4289. doi: 10.3892/ol.2017.5989. Epub 2017 Apr 5.
3
[Application of imatinib in BCR- ABL positive acute lymphoblastic leukemia treatment in the real world].
伊马替尼在真实世界中治疗BCR-ABL阳性急性淋巴细胞白血病的应用
Zhonghua Xue Ye Xue Za Zhi. 2016 Oct 14;37(10):886-891. doi: 10.3760/cma.j.issn.0253-2727.2016.10.014.
4
Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.造血细胞激酶(HCK)作为免疫细胞和癌细胞的治疗靶点。
Oncotarget. 2015 Jun 30;6(18):15752-71. doi: 10.18632/oncotarget.4199.
5
Src family kinases interfere with dimerization of STAT5A through a phosphotyrosine-SH2 domain interaction.Src家族激酶通过磷酸酪氨酸-SH2结构域相互作用干扰STAT5A的二聚化。
Cell Commun Signal. 2015 Feb 15;13:10. doi: 10.1186/s12964-014-0081-7.
6
Current concepts in pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia.儿童费城染色体阳性急性淋巴细胞白血病的当前概念
Front Oncol. 2014 Mar 25;4:54. doi: 10.3389/fonc.2014.00054. eCollection 2014.
7
Expression and activity of Fyn mediate proliferation and blastic features of chronic myelogenous leukemia.Fyn 的表达和活性介导慢性髓性白血病的增殖和原始细胞特征。
PLoS One. 2012;7(12):e51611. doi: 10.1371/journal.pone.0051611. Epub 2012 Dec 17.
8
Indirubin derivatives induce apoptosis of chronic myelogenous leukemia cells involving inhibition of Stat5 signaling.靛玉红衍生物通过抑制 Stat5 信号诱导慢性髓系白血病细胞凋亡。
Mol Oncol. 2012 Jun;6(3):276-83. doi: 10.1016/j.molonc.2012.02.002. Epub 2012 Feb 17.
9
Co-expression vs. co-infection using baculovirus expression vectors in insect cell culture: Benefits and drawbacks.杆状病毒表达载体在昆虫细胞培养中的共表达与共感染:优缺点。
Biotechnol Adv. 2012 May-Jun;30(3):766-81. doi: 10.1016/j.biotechadv.2012.01.009. Epub 2012 Jan 28.
10
From Hen House to Bedside: Tracing Hanafusa's Legacy from Avian Leukemia Viruses to SRC to ABL and Beyond.从鸡舍到病床边:追溯花房从禽白血病病毒到SRC再到ABL及其他的遗产。
Genes Cancer. 2010 Dec;1(12):1164-9. doi: 10.1177/1947601911407327.